If price action maintains levels above the basis of the BB then it should signal strength hopefully resulting in a breakout out of its symmetrical triangle to the 0.618 fib at $6.46 which implies a possible ~50% move towards the upside
It's nice tringle, good news from the company last few days, giving us big hope to move up share up to price - 4.13$ and then to entry price - 4.30$. Target price 5.50$, in the long term, expected more than 10$. It's not financial advice, only my privet ideas. Look to my ideas for different stocks. Good luck!!!!
$ABUS have a high evaluation above 5.5$ while its currently trading at 3.6 $ expecting profiting from $MRNA and $PFE patent royalties , currently touching rising trend line and it could be a good entry to start accumulating
Arbutus is on a wild ride of late, huge volatility has come into it since Nov as the vaccines came closer to being deployed, I have done a huge amount of DD on this stock and I am very very confident of 3X min by mid 2021. Brief outline of what is going on: Main catalyst in the coming years is Hep B vaccine/cure that may be able to dose as little as every 12...
Trading in a channel. I like the channel, The MACD looks like its turning to the upside, we are near a bottom of the channel, volume is low but we are near the 20 and 50 day MA... First target is at 4.95 - 5.00 This is where I would be taking most of my profits and re-assessing. Tight stop loss or monitoring is necessary.
Looks primed and ready for bull-break 20ma break is the key
$3.60 arrea was heavy resistance, now it's strong support. Touching trend line and Over sold RSI tuning green, prepping for another run up. Yahoo Finance says it's 26% under valued. Looks like a decent entry point with a SL below $3.60 Heavy Resistance at $4.50 and could turn into a H+S
Hi traders . NASDAQ:ABUS Following this ticker for some time and looking on play scenarios . News out there on patent etc are currently not in play IMO . But over all company has good fundamentals and we will try yo make some profits on it . There are some fundamental flaws and areas selected on chart and are my interest zones . I personally would...
Contextual immersion trading strategy idea. Arbutus Biopharma Corporation, a biopharmaceutical company, engages in the discovery, development, and commercialization of a cure for patients suffering from chronic Hepatitis B virus (HBV) infection in the United States. The demand for shares of the company looks higher than the supply. This and other conditions can...
BREAKOUT STOCK ALERT UPDATE $ABUS - Arbutus Biopharma Corporation - Common Stock Initial Alert Price: $3.73 Price High: $5.23 % Gains/Losses: 40.21% (40% More Than Expected) Stop Loss Limit: $4.97 Looking for ABUS to bounce through the $4.10 Levels of Resistance and retest the $5.00 Levels once again, at least $4.50. #Breakout #Stocks #Trading #Investing #Alerts...
BREAKOUT STOCK ALERT $ABUS - Arbutus Biopharma Corporation - Common Stock Initial Alert Price: $3.73 Potential Price: $4.50 Potential Gains: 21% Stop Loss Limit: $3.54 Looking for ABUS to bounce through the $4.10 Levels of Resistance and retest the $5.00 Levels once again, at least $4.50. #Breakout #Stocks #Trading #Investing #Alerts #StockMarket #Daily #News...
...Another single stock opportunity that is worth building a bridge over; $ABUS (Arbutus Biopharma) an excellent and cheap shelter for the next chapter in covid flows. The beauty of choice! It is interesting as all covid vaccines will have to RNA IP .. this is a convincing driver. As well as creating a shelter, use the intimately linked highs to add and...
Arbutus Biopharma is an interesting stock. There's a lot to know about it. First of all they are trying to find a functional cure of HepB, this is called AB-729 and it is in the late stage 1 trials. They have announced results from a single dose study which were VERY positive and we are awaiting results from multi-dose part of the trial which should be announced...